Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genomic abnormalities of TP53define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma

Autor: Newman, Alexander M., Zaka, Masood, Zhou, Peixun, Blain, Alex E., Erhorn, Amy, Barnard, Amy, Crossland, Rachel E., Wilkinson, Sarah, Enshaei, Amir, De Zordi, Julian, Harding, Fiona, Taj, Mary, Wood, Katrina M., Televantou, Despina, Turner, Suzanne D., Burke, G. A. Amos, Harrison, Christine J., Bomken, Simon, Bacon, Chris M., Rand, Vikki

Publikováno v: Leukemia; March 2022, Vol. 36 Issue: 3 p781-789, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma.

Autor: Newman AM; School of Health & Life Sciences, Teesside University, Middlesbrough, UK.; National Horizons Centre, Teesside University, 38 John Dixon Lane, Darlington, UK.; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Zaka M; School of Health & Life Sciences, Teesside University, Middlesbrough, UK.; National Horizons Centre, Teesside University, 38 John Dixon Lane, Darlington, UK.; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Zhou P; School of Health & Life Sciences, Teesside University, Middlesbrough, UK.; National Horizons Centre, Teesside University, 38 John Dixon Lane, Darlington, UK.; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Blain AE; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Erhorn A; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Barnard A; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Crossland RE; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Wilkinson S; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Enshaei A; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., De Zordi J; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Harding F; Newcastle Genetics Laboratory, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Taj M; Department of Paediatric Oncology, Royal Marsden Hospital, Sutton, Surrey, UK., Wood KM; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Televantou D; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Turner SD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; CEITEC, Masaryk University, Brno, Czech Republic., Burke GAA; Department of Paediatric Haematology, Oncology and Palliative Care, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Harrison CJ; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Bomken S; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Paediatric and Adolescent Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Bacon CM; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Rand V; School of Health & Life Sciences, Teesside University, Middlesbrough, UK. v.rand@tees.ac.uk.; National Horizons Centre, Teesside University, 38 John Dixon Lane, Darlington, UK. v.rand@tees.ac.uk.; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. v.rand@tees.ac.uk.

Publikováno v: Leukemia [Leukemia] 2022 Mar; Vol. 36 (3), pp. 781-789. Date of Electronic Publication: 2021 Oct 21.